Neomycin Sulfate(for veterinary)

Producers shown on SFDA

(Record date:29/10/2021）

Producers shown on EP

Not showing any

Producer:Lifecome Biochemistry Co., Ltd. was established in 2003. 

The product quality of the company meets the Chinese veterinary drug code and USP and PH. EUR Pharmacopoeia standards, and has passed the GMP acceptance of veterinary drugs of the Ministry of agriculture of China, EU-GMP acceptance, GMP acceptance of veterinary drug management department of Australia, ISO14001 environmental management system certification and iso45001 occupational health and safety management system certification; Methylene salicylic acid bacitracin premix product has been approved as five new veterinary drugs by the Ministry of agriculture of China; Methylsalicylic acid bacitracin and methylsalicylic acid bacitracin soluble powder have been approved as class II new veterinary drugs by the Ministry of agriculture of China; The methylene salicylate bacitracin production line passed the on-site inspection of GMP in the United States; Natamycin products have passed ISO9001 quality management system certification, food safety management system certification (ISO22000), international halal certification (HALAL) and international kosher certification (KOSHER).

Staff size:600-699 people

Registered capital:RMB 155 million 400 thousand

Website: http://www.lifecomepc.com

Producer:Yichang Sanxia Pharmaceutical Co., Ltd.is a wholly-owned subsidiary of humanwell Pharmaceutical Group. The company is a national high-tech enterprise. It is a comprehensive biopharmaceutical enterprise that studies and produces antibiotic API, amino acid series high-capacity injections and animal drug preparations.

The company is a large global supplier of neomycin sulfate API. Its subdivided product line covers neomycin sulfate for animals, Fraxinus sulfate, neomycin sulfate for prescription people in the United States, etc. its products have passed the certification of FDA and CEP of the European Union, with a global market share of more than 80%. Neomycin sulfate has won the title of "single champion product" in the national manufacturing industry. The company is also one of the earliest manufacturers of amino acid high-volume injections in China. At present, it mainly produces compound amino acid infusion and other basic infusion with product specifications of 3AA, 6Aa, 9aa, 15aa, 17aa, 17aa-i and 18AA, and the product specifications of various soft bags and glass bottles have reached 46. Among them, "Three Gorges brand" series amino acid high-volume injections are recognized as "famous brand products" and "high-quality products" in Hubei Province. The sales volume of compound amino acid injection 3AA accounts for more than 50% in China.

Staff size:1000-1999 people

Registered capital:RMB 390 million

Website: http://www.sanxiapharm.com

Producer:Yantai Justaware Pharmaceutical Co., Ltd., established in 2014, is a wholly-owned subsidiary of Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.

Established in 1988, Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. has an annual production capacity of 400 tons of API, 1 billion tablets, 100 million small volume injections and 5 million lyophilized powder injections.

Staff size:About 50 people

Registered capital: RMB 5 million

Website: http://www.justaware.com

Producer:Cangzhou Lingang Yanuo Biopharma Co., Ltd., established in 2006, covers an area of 218 mu. It is a wholly-owned subsidiary of Hebei Yanuo Bioscience Co., Ltd.

Yanuo Bioscience's main business covers two business segments: fine chemicals and biomedicine. At present, it has three production bases in Shijiazhuang, Cangzhou and Wuhai, all of which have passed the ISO9001, ISO 45001 and ISO14001 international management system certification. The biomedical section can meet and ensure the large-scale continuous production of veterinary drugs, pharmaceutical intermediates, technical drugs and other varieties. With GMP purification workshop, it can meet the production needs of biological preparations, oral preparations and other related preparations.

Registered capital:RMB 40 million

Website: http://www.yanuo.com

Producer:Zhumadian Huazhong Zhengda Co., Ltd. was established in 1996. The company covers an area of 200 mu. It mainly produces and operates veterinary drug additive - feed grade aureomycin.

The company has passed IS09002 international quality system certification, GMP certification of the Ministry of agriculture and FDA certification.

Staff size:300-399 people

Registered capital:RMB 72 million

Website: http://www.zdjms.com

The company's main products have passed FDA, EDQM and APVMA certification.

Staff size:600-699 people

Registered capital:RMB 73.33062 million

Website: http://www.qilupharma.com

Producer:Xinyao Xinrui Pharmacy Co., Ltd. was founded in 2016, and is the leading product of neomycin sulfate production, with an annual capacity of 130 trillion and 1 billion. It is a comprehensive animal pharmaceutical enterprise integrating development, development, production and sales.

Staff size:200-299 people

Registered capital:RMB 50 million

Website: http://www.jyxrzy.com

The company's products are of excellent quality and have successively obtained ISO9001:2008 quality management system certificate, China veterinary drug GMP certificate, EU CEP registration certificate and EU GMP certificate.

Staff size:200-299 people

Registered capital:RMB 3 million

Website: http://www.dctangshan.com

Producer:Xinyu Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based on research and development and production of microbiological drugs, the National High-tech Enterprise, Anhui Province's first batch of technology innovation enterprises, Anhui Province's production, education and research demonstration enterprises, Anhui Province AAA credit enterprises. The company covers an area of 500 mu, with the total assets of 1 billion yuan.

The company has established a sound quality assurance system, all production lines have passed the national GMP certification. The company is set up as the pharmaceutical GMP practice training base by Anhui Provincial Food and Drug Administration. Lincomycin hydrochloride production line has passed America FDA certification, German GMP certification, Spain, Canada, Japan and other countries registered. Lincomycin hydrochloride, clindamycin phosphate obtained CEP certificate. 

Staff size:About 700 people

Registered capital:RMB 90 million 

Website: http://www.xinyu-pharm.com

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978